Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE & ESE 2025
COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest...
Brain
Buy Ibutamoren MK 677 SARMS for Sale Online: MK-677 Before After Results – Where to Order Legal Ibutamoren SARM OTC, Buyers Guide from CrazyBulk
CrazyBulk CrazyBulk New York City, May 03, 2025 (GLOBE NEWSWIRE) -- If you’re serious about packing on size, crushing PRs,...
Bioma Review 2025: Revolutionizing Gut Health or Just Another Fad? Honest Analysis Inside By Bioma Probiotic!
Gut transformation through Bioma a perfectly blended combination of probiotics prebiotics and postbiotics Bioma Bioma New York City, May 03,...
Javy Protein Coffee Under Review: Best Protein Coffee with Premium Ingredients by Javy Protein Coffee
Discover why Javy Protein Coffee is the best protein coffee for energy, recovery, and flavor. Fast, convenient, zero sugar—perfect for...
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
The company will showcase innovations designed to optimize the oncology care workflow and enable improved patient outcomes CHICAGO--(BUSINESS WIRE)--GE HealthCare...
MIB acquires Clareto, forming strategic partnership with Munich Re Life US to expand access to electronic medical data and develop advanced data analytics
BRAINTREE, Mass. and NEW YORK, May 2, 2025 /PRNewswire/ -- MIB, the life insurance industry's most trusted and secure partner for...
RaySearch releases RayStation v2025
STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* v2025, the latest version of...
Fueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma Research Investment
WASHINGTON, May 1, 2025 /PRNewswire/ -- The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced...
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
John Woock joins as Chief Business Officer; Konstantinos Alataris, PhD, appointed to Board of DirectorsNEW YORK, May 01, 2025 (GLOBE...
Natus announces integration of InVisus Pro NMUS into Natus Elite software
MIDDLETON, Wis., April 30, 2025 /PRNewswire/ -- Natus Medical Incorporated has announced its InVisus Pro Neuromuscular Ultrasound system can now...
XingImaging Unveils NX PET Camera to Advance Parkinson’s Disease Research
NEW HAVEN, Conn., April 30, 2025 /PRNewswire/ -- XingImaging, a MITRO company, a pioneer in advanced research imaging, radiopharmaceutical services,...
Annals of Family Medicine: Four New Studies Test Digital and Artificial Intelligence Screening Tools in Family Medicine
New research in Annals of Family Medicine explores the use of artificial intelligence, apps, and tablets to detect dementia, heart dysfunction,...
MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety
Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at...
MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety
Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at...
MindLight Video Game Launches to Empower Children to Manage Stress and Anxiety
Using Biometric Feedback, MindLight Turns Emotions into Real-Time Game Inputs to Improve Mental Health; Scientifically-Proven to Decrease Anxiety by at...
LEVEL EX LAUNCHES LEVEL ONE, A FREE MOBILE GAME TO REDEFINE TYPE 1 DIABETES ONBOARDING
Now available on iOS and Android, Level One helps newly diagnosed Type 1 Diabetics and their caregivers master insulin management...
LEVEL EX LAUNCHES LEVEL ONE, A FREE MOBILE GAME TO REDEFINE TYPE 1 DIABETES ONBOARDING
Now available on iOS and Android, Level One helps newly diagnosed Type 1 Diabetics and their caregivers master insulin management...
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025...
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignanciesVANCOUVER, British Columbia, April 29, 2025...
Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases
- Novel approach to treat neurodegenerative diseases by targeting fibrin-driven neuroinflammation was well-tolerated among healthy volunteers, with a clean hematological...